The relationship of SHP1 expression in liver tissues with the activation and proliferation of hepatic stellate cells in vivo during the pathologic processes of hepatic fibrosis in rats

doi:10.12047/j.cjap.6205.2022.011

Abstract

CLC Number:

R575.2

HAO Li-sen, CHEN Pan-pan, JIN Li-min, ZHAN Zong-yuan, YANG Xiao-shi, JI Jing-xiu, JIANG Mei-yu, MO Yan-bo. The relationship of SHP1 expression in liver tissues with the activation and proliferation of hepatic stellate cells in vivo during the pathologic processes of hepatic fibrosis in rats[J]. CJAP, 2022, 38(1): 58-61.

References

[1] Ezhilarasan D, Sokal E, Najimi M. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets [J]. Hepatobiliary Pancreat Dis Int, 2018, 17(3): 192-197.
[2] Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis [J]. Adv Drug Deliv Rev, 2017, 121: 27-42.
[3] Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation [J]. Nat Rev Gastroenterol Hepatol, 2017, 14(7): 397-411.
[4] Varone A, Spano D, Corda D. Shp1 in solid cancers and their therapy [J]. Front Oncol, 2020, 10: 935.
[5] López-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, et al. SHP-1 in cell-cycle regulation [J]. Anticancer Agents Med Chem, 2011, 11(1): 89-98.
[6] Adhikari A, Martel C, Marette A, et al. Hepatocyte SHP-1 is a critical modulator of inflammation during endotoxemia [J]. Sci Rep, 2017, 7(1): 2218.
[7] Tibaldi E, Zonta F, Bordin L, et al. The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling [J]. Biochim Biophys Acta, 2014, 1843(2): 288-298.
[8] Su TH, Shiau CW, Jao P, et al. Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition[J]. Proc Natl Acad Sci U S A, 2015, 112(23): 7243-7248.
[9] Nakamura T, Akiyoshi H, Saito I, et al. Adenovirus-mediated gene expression in the septal cells of cirrhotic rat livers [J]. J Hepatol, 1999, 30(1): 101-106.
[10] Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis [J]. Compr Physiol, 2013, 3(4): 1473-1492.
[11] Su TH, Shiau CW, Jao P, et al. Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis [J]. Sci Rep, 2017, 7(1): 1728.
[12] 陈信信, 张晓芸, 丁玉真, 等. 剪切应力环境下的内皮祖细胞对肝星状细胞增殖和生物功能的影响[J]. 中国应用生理学杂志, 2018, 34(5): 404-407.
[13] 阮建佳, 杜岩. 神经酰胺合酶-神经酰胺通路在青蒿琥酯抑制肝纤维化中的作用[J]. 中国应用生理学杂志, 2020, 36(3): 279-282.
[14] Yang J, Liu L, He D, et al. Crystal structure of human protein-tyrosine phosphatase SHP-1 [J]. J Biol Chem, 2003, 278(8): 6516-6520.
[15] Wang W, Liu L, Song X, et al. Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation [J]. J Cell Biochem, 2011, 112(8): 2062-2071.